- Display 15 Products per page
Published: October 1, 2010 | Price: $2,995.00 – $5,990.00
Infusion pumps are used to infuse necessary fluids, which includes medications and/or nutrients, to a patient’s circulatory system. This Kalorama Information report, Infusion Pump Markets (Large Volume, Ambulatory, Disposable, Syringe, and Specialty Infusion Pumps) covers markets for these products in several product segments. Estimates and Forecasts of Infusion Pump Markets For the purpose of this study, we have classified two general types of infusion pumps: General Purpose Infusion Pumps and Specialty Infusion Pumps General purpose infusion pumps are used in...Published: July 1, 2004 | Price: $895.00 – $1,790.00
Alternative routes of administration for insulin has been one of the leading drivers of drug delivery industry. Although transdermal and transmucosal systems have shown promise and true oral delivery remains a goal, pulmonary delivery has emerged as the leading area of development. Several major players in the pharmaceutical industry have given their backing to inhaled insulin projects, and product launches are imminent. However, the exact make-up of the market, patient acceptance, and regulatory progress are still not completely clear. This...Published: December 20, 2017 | Price: $2,640.00 – $5,280.00
Bundle of report sections including Molecular Assay Procedures Inherited Disease Markets Cancer MarkersPublished: March 26, 2015 | Price: $499.00 – $1,000.00
Insulin Infusion Pumps: World Market Analysis Infusion pumps are used to infuse necessary fluids, including medications and/or nutrients, to a patient’s circulatory system. They delivere insulin precisely and continuously to ensure normal function. Insulin Infusion Pumps: World Market Analysis analyzes the present and future world market for these pumps, with market forecasts to 2019. Several leading competitors and product developers are listed in the manufacturer profiles. The profiled companies include: Animas Corporation/Johnson & Johnson Asante Solutions Cellnovo Insulet Corporation Medtronic...Published: September 19, 2019 | Price: $5,000.00 – $10,000.00
By 2020, it is estimated that there will be 21 billion connected devices in the world. That will be five times as many as just four years ago. This fact affects healthcare as much as any industry. Internet of Things (IoT) in Healthcare tracks the trends around IoT in healthcare and makes specific market estimates and forecasts. The industry adoption of technology in healthcare is driven by an increase in government mandates, staffing shortages, improving clinical outcomes, and increasing pressures...Published: August 5, 2013 | Price: $1,995.00 – $3,990.00
Australia represents a highly competitive IVD market with established international players, a highly developed export-intensive domestic industry, and highly consolidated clinical lab and testing industry. While other developed IVD markets in North America, Europe and Japan are not estimated to be achieving above 3% annual growth, the Australian IVD market has grown at an average of roughly 5% through the past five years. This rate of growth is projected to more or less continue with a stable funding environment through...Published: August 5, 2013 | Price: $2,500.00 – $5,000.00
This report, IVD in China represents Kalorama's complete analysis on the Chinese IVD market. The report provides an introduction to the healthcare system in China, the results of recent reform efforts, and issues and trends. Regional breakouts of the Chinese system are provided. The report describes the role that out-of-pocket expenditures and private concerns play in the delivery of healthcare in the nation. The modern Chinese healthcare market was borne of and continues to be guided by the progressive intentions...Published: April 12, 2018 | Price: $3,995.00 – $7,990.00
IVD in China As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. This report provides the following market data: Market by Province (Guangdong, Shangdong, Henan, Sichuan, Jiangsu, Hebei, Hunan, Anhui, Zhejiang,...Published: June 11, 2015 | Price: $1,995.00 – $3,995.00
IVD in China Market Outlook 2014-2024 With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro diagnostics (IVD) market, China trails only the populous, developed markets of the United States, western European countries,...Published: September 9, 2018 | Price: $5,000.00 – $10,000.00
Kalorama Information 2018 Regional IVD Market Bundle (IVD in China, The IVD Market in South Korea, The IVD Market in Vietnam) This Kalorama Information (KI) Market Research Bundle is a combination of 3 complete KI in vitro diagnostics (IVD) reports, including IVD in China, The IVD Market in South Korea and The IVD Market in Vietnam. The reports provide an overview of the IVD markets in China, South Korea and Vietnam. The revenue data provided give an overview of developments...Published: September 18, 2018 | Price: $3,500.00 – $7,990.00
IVD in Eastern Europe IVD companies continue to explore opportunities in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. These countries continue to invest in healthcare infrastructure and insurance coverage for a growing more affluent middle class. Eastern European markets are ripe for change. Many countries are engaging in healthcare reform programs to meet the growing demand for innovative products while containing costs in an increasingly...Published: January 6, 2016 | Price: $3,360.00 – $6,720.00
IVD in India IVD in India provides analysis of the Indian IVD industry and presents projections to 2025, featuring estimates of the total opportunity and its component sectors, including: total IVD revenues in India, 2015-2025, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2015, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2020, and IVD revenues in India by market sector (immunoassays, clinical chemistry,...Published: December 16, 2013 | Price: $995.00 – $1,990.00
Full coverage of the IVD market in Mexico, including important IVD segments.Published: January 1, 2014 | Price: $1,995.00 – $3,995.00
IVD in Singapore and Malaysia Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia. IVD in Singapore and Malaysia contains the following information: Healthcare Statistics for Singapore and Malaysia Significant Hospitals in both countries The Clinical Lab Market in...Published: October 4, 2016 | Price: $2,396.00 – $4,792.00
IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast) In vitro diagnostic (IVD) companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. The Middle East is an underserved region with large market potential. IVD in the Middle East provides data on the developments in the IVD industry in the Middle East, including: Egypt...